On the other hand, Dubois et al. [39] initially reported 22%, and thereafter up to 24%, frequency of EZH2 Y641 mutations in GC-DLBCL, which is slightly higher than initially reported by Morin et al. (n = 18/83, 21.7%) [40]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.